title: Mycophenolate mofetil treatment of crescentic Henoch-Schönlein nephritis with IgA depositions.
abstract: Mycophenolate mofetil (MMF) is considered to be a promising therapeutic agent in primary glomerulonephritis but there are no data on the use of MMF in Henoch-Schönlein nephritis (HSN). Herein we report the first adult crescentic HSN patient in whom long-term complete remission was achieved after MMF therapy.
authors.affiliation: Department of Nephrology, Ankara Numune Training and Research Hospital, Ankara, Turkey. fatded@yahoo.com
authors.forename: Fatih
authors.initials: F
authors.lastname: Dede
authors.forename: Birgul
authors.initials: B
authors.lastname: Onec
authors.forename: Deniz
authors.initials: D
authors.lastname: Ayli
authors.forename: Ipek Isik
authors.initials: II
authors.lastname: Gonul
authors.forename: Kursad
authors.initials: K
authors.lastname: Onec
mesh_terms: D000328:Adult; D001706:Biopsy; D018450:Disease Progression; D004305:Dose-Response Relationship, Drug; D005260:Female; D005500:Follow-Up Studies; D005922:Glomerulonephritis, IGA / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D006801:Humans; D011695:IgA Vasculitis / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007668:Kidney / Q000473:pathology; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011355:Prodrugs; D012074:Remission Induction / Q000379:methods
chemical_list: D007166:Immunosuppressive Agents; D011355:Prodrugs; D009173:Mycophenolic Acid